Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF‐κB pathway and ameliorates atherosclerosis
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7962 ↗At a glance
Journal article in Phytotherapy Research, 2023. Written by Xiuzhu Weng and 13 co-authors. Institution: Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China. Major MEDLINE topics: NF-kappa B, Atherosclerosis. Cited 43 times so far (Crossref); 70 references. Funded by: Fund of Key Laboratory of Myocardial Ischemia, Ministry of Education, Key Research and Development Plan of Heilongjiang Science and Technology Department, National Natural Science Foundation of China.
Abstract (original language)
Pyroptosis plays an important role in inflammatory diseases such as viral hepatitis and atherosclerosis. Apigenin exhibits various bioactivities, particularly anti‐inflammation, but its effect on pyroptosis remains unclear. The aim of this study is to investigate the effect of apigenin on pyroptosis and explore its potential against inflammatory diseases. THP‐1 macrophages treated by lipopolysaccharides/adenosine 5′‐triphosphate were used as the in vitro pyroptosis model. Western blot was used to detect the expression of NLRP3 inflammasome components and key regulators. Immunofluorescence was used to observe ROS production and intracellular location of p65. The potential of apigenin against inflammatory diseases was evaluated using atherosclerotic mice. Plaque progression was observed by pathological staining. Immunofluorescence was used to observe the expression of NLRP3 inflammasome components in plaques. The results showed that apigenin inhibited NLRP3 inflammasome activation. Apigenin reduced ROS overproduction and inhibited p65 nuclear translocation. Additionally, apigenin decreased the expression of NLRP3 inflammasome components in the plaque. Plaque progression was inhibited by apigenin. In conclusion, apigenin exhibited a preventive effect on macrophage pyroptosis by reducing oxidative stress and inhibiting the NF‐κB pathway. Apigenin may alleviate atherosclerosis at least partially by inhibiting macrophage pyroptosis. These findings suggest apigenin to be a promising therapeutic agent for inflammatory diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
- National Key Laboratory of Frigid Zone Cardiovascular Diseases, Harbin, People's Republic of China.
ORCID profiles: Haibo Jia
Funding
- Fund of Key Laboratory of Myocardial Ischemia, Ministry of Education
- Key Research and Development Plan of Heilongjiang Science and Technology Department
- National Natural Science Foundation of China
Cite
APA
Weng, X., Luo, X., Dai, X., Lv, Y., Zhang, S., Bai, X., Bao, X., Wang, Y., Zhao, C., Zeng, M., Hu, S., Li, J., Jia, H., & Yu, B. (2023). Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF‐κB pathway and ameliorates atherosclerosis. Phytotherapy Research. https://doi.org/10.1002/ptr.7962
Vancouver
Weng X, Luo X, Dai X, Lv Y, Zhang S, Bai X, et al. Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF‐κB pathway and ameliorates atherosclerosis. Phytotherapy Research. 2023. doi:10.1002/ptr.7962
BibTeX
@article{Weng2023,
author = {Weng, Xiuzhu and Luo, Xing and Dai, Xinyu and Lv, Ying and Zhang, Shan and Bai, Xiaoxuan and Bao, Xiaoyi and Wang, Ying and Zhao, Chen and Zeng, Ming and Hu, Sining and Li, Ji and Jia, Haibo and Yu, Bo},
title = {Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF‐κB pathway and ameliorates atherosclerosis},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7962}
}
EUVIMED